Zimmer Biomet Holdings (ZBH) Stock Statistics & Valuation Metrics

Zimmer Biomet Holdings has a market cap or net worth of $15.96B. The enterprise value is $22.55B.

Zimmer Biomet Holdings has 193,569,080 shares outstanding. The number of shares has decreased by -2.65% in one year.

Zimmer Biomet Holdings’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 5.48%.

The current PE Ratio of Zimmer Biomet Holdings is ―. Zimmer Biomet Holdings’s PEG ratio is -1.26.

In the last 12 months, Zimmer Biomet Holdings had revenue of 8.23B and earned 705.20M in profits. Earnings per share was 3.56.

In the last 12 months, operating cash flow was 1.67B and capital expenditures 162.10M, giving a free cash flow of 1.84B billion.

Zimmer Biomet Holdings pays an annual dividend of $0.24, resulting in a dividend yield of 1.05%

Zimmer Biomet Holdings upcoming earnings date is Aug 4, 2026, Before Open (Confirmed).

Zimmer Biomet Holdings as a current ratio of 1.98, with Debt / Equity ratio of 50.69%

In the past 12 months, Zimmer Biomet Holdings has paid 125.70M in taxes.

Zimmer Biomet Holdings EV to EBITDA ratio is 11.15, with an EV/FCF ratio of 16.80.

Zimmer Biomet Holdings has $424.20M in cash and marketable securities with $7.47B in debt, giving a net cash position of -$7.05B billion.

Gross margin is 70.03%, with operating margin of 16.55%, and net profit margin of 8.57%.

The average price target for Zimmer Biomet Holdings is $96.19, which is 11.43% higher than the current price. The consensus rating is Hold